Akums Drugs and Pharmaceuticals has reported results for third quarter ended December 31, 2024 (Q3FY25)
The company has reported 40.32% rise in net profit at Rs 41.17 crore for Q3FY25 as compared to Rs 29.34 crore for the same quarter in the previous year. Total income of the company decreased by 9.02% at Rs 371.25 crore for Q3FY25 as compared to Rs 408.04 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 65.99% fall in its net profit at Rs 66.31 crore for the quarter ended December 31, 2024 as compared to Rs 195.00 crore for the same quarter in the previous year. Total income of the company decreased by 6.12% at Rs 1024.97 crore for Q3FY25 as compared to Rs 1091.75 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1788.35 |
Dr. Reddys Lab | 1170.55 |
Cipla | 1524.75 |
Lupin | 2048.40 |
Zydus Lifesciences | 865.20 |
View more.. |